Allscripts (MDRX) Misses Q1 EPS by 12c; Lowers FY12 Outlook; 4 Directors, CFO to Leave
Tweet
Share
E-mailGet Alerts MDRX Hot Sheet
Join SI Premium – FREE
Allscripts (NASDAQ: MDRX) reported Q1 EPS of $0.12, $0.12 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $364.7 million versus the consensus estimate of $387.82 million.
Allscripts sees FY2012 EPS of $0.74-$0.80, versus prior guidance of $1.06-$1.10 and the consensus of $1.09.
Allscripts also announced that Bill Davis, Chief Financial Officer, has decided to leave the Company, effective May 18, 2012, to pursue another opportunity with a private company outside of the healthcare industry.
The Company also announced that Phil Pead's service as Chairman of the Board, director and officer of the Company terminated yesterday. Prior to this action, the Board engaged in extensive deliberations regarding the leadership of the Company. Following the deliberations, those who concurred with the consensus regarding such leadership expressed their intention to continue as directors, and those who did not concur (Catherine M. Burzik, Eugene V. Fife and Edward A. Kangas) informed the Company that they have resigned as directors. The Company expects that several additional directors will be appointed shortly.
For earnings history and earnings-related data on Allscripts (MDRX) click here.
Allscripts sees FY2012 EPS of $0.74-$0.80, versus prior guidance of $1.06-$1.10 and the consensus of $1.09.
Allscripts also announced that Bill Davis, Chief Financial Officer, has decided to leave the Company, effective May 18, 2012, to pursue another opportunity with a private company outside of the healthcare industry.
The Company also announced that Phil Pead's service as Chairman of the Board, director and officer of the Company terminated yesterday. Prior to this action, the Board engaged in extensive deliberations regarding the leadership of the Company. Following the deliberations, those who concurred with the consensus regarding such leadership expressed their intention to continue as directors, and those who did not concur (Catherine M. Burzik, Eugene V. Fife and Edward A. Kangas) informed the Company that they have resigned as directors. The Company expects that several additional directors will be appointed shortly.
For earnings history and earnings-related data on Allscripts (MDRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grainger (GWW) Tops Q1 EPS by 2c, provides guidance
- ACNB Corporation (ACNB) Reports In-Line Q1 EPS
- Cullen/Frost Bankers (CFR) Misses Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, Guidance, Management ChangesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
